236 related articles for article (PubMed ID: 8683940)
1. Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression.
Daniels KJ; Boldt HC; Martin JA; Gardner LM; Meyer M; Folberg R
Lab Invest; 1996 Jul; 75(1):55-66. PubMed ID: 8683940
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas.
Sahin A; Kiratli H; Tezel GG; Soylemezoglu F; Bilgic S
Ophthalmic Res; 2007; 39(1):40-4. PubMed ID: 17164576
[TBL] [Abstract][Full Text] [Related]
3. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma.
Clarijs R; Otte-Höller I; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):912-8. PubMed ID: 11923228
[TBL] [Abstract][Full Text] [Related]
4. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma.
Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2471-80. PubMed ID: 10509639
[TBL] [Abstract][Full Text] [Related]
5. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
6. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
[TBL] [Abstract][Full Text] [Related]
8. Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers.
Hendrix MJ; Seftor EA; Seftor RE; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
Lab Invest; 1998 Feb; 78(2):153-63. PubMed ID: 9484713
[TBL] [Abstract][Full Text] [Related]
9. Distinguishing fibrovascular septa from vasculogenic mimicry patterns.
Lin AY; Maniotis AJ; Valyi-Nagy K; Majumdar D; Setty S; Kadkol S; Leach L; Pe'er J; Folberg R
Arch Pathol Lab Med; 2005 Jul; 129(7):884-92. PubMed ID: 15974811
[TBL] [Abstract][Full Text] [Related]
10. The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma.
Mudhar HS; Saunders E; Rundle P; Rennie IG; Sisley K
Br J Ophthalmol; 2009 Apr; 93(4):535-40. PubMed ID: 19019926
[TBL] [Abstract][Full Text] [Related]
11. The microcirculation of choroidal and ciliary body melanomas.
Folberg R; Mehaffey M; Gardner LM; Meyer M; Rummelt V; Pe'er J
Eye (Lond); 1997; 11 ( Pt 2)():227-38. PubMed ID: 9349418
[TBL] [Abstract][Full Text] [Related]
12. Angiogenic profile of uveal melanoma.
Notting IC; Missotten GS; Sijmons B; Boonman ZF; Keunen JE; van der Pluijm G
Curr Eye Res; 2006 Sep; 31(9):775-85. PubMed ID: 16966150
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiological implications of stroma pattern formation in uveal melanoma.
Clarijs R; Ruiter DJ; De Waal RM
J Cell Physiol; 2003 Mar; 194(3):267-71. PubMed ID: 12548547
[TBL] [Abstract][Full Text] [Related]
14. Differential S100 beta expression in choroidal and skin melanomas: quantitation by the polymerase chain reaction.
Kan-Mitchell J; Liggett PE; Taylor CR; Rao N; Granada ES; Danenberg KD; White WL; Van Eldik LJ; Horikoshi T; Danenberg PV
Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3366-75. PubMed ID: 8225871
[TBL] [Abstract][Full Text] [Related]
15. Microcirculation patterns other than loops and networks in choroidal and ciliary body melanomas.
Folberg R; Chen X; Boldt HC; Pe'er J; Brown CK; Woolson RF; Maniotis AJ
Ophthalmology; 2001 May; 108(5):996-1001. PubMed ID: 11320035
[TBL] [Abstract][Full Text] [Related]
16. Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma.
Mäkitie T; Carpén O; Vaheri A; Kivelä T
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2442-9. PubMed ID: 11581181
[TBL] [Abstract][Full Text] [Related]
17. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
18. Local environmental influences on uveal melanoma: vitreous humor promotes uveal melanoma invasion, whereas the aqueous can be inhibitory.
Canovas D; Rennie IG; Nichols CE; Sisley K
Cancer; 2008 Apr; 112(8):1787-94. PubMed ID: 18300240
[TBL] [Abstract][Full Text] [Related]
19. KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors.
Al-Jamal RT; Kivelä T
Curr Eye Res; 2006 Jan; 31(1):57-67. PubMed ID: 16421020
[TBL] [Abstract][Full Text] [Related]
20. Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension.
Heindl LM; Hofmann TN; Knorr HL; Rummelt C; Schrödl F; Schlötzer-Schrehardt U; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Invest Ophthalmol Vis Sci; 2009 May; 50(5):1988-95. PubMed ID: 19151383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
